By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Thermo Fisher Scientific today announced it has extended its $2.1 billion offer to purchase Dionex.

Its offer to acquire all outstanding shares of the chromatography firm at $118.50 per share is now set to expire at midnight EDT Feb. 17. All other terms of the deal remain, the company said, adding the acquisition is anticipated to be completed later this quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.